mRNA-Based Therapeutics Summit Europe - What's On?
Following the successful development of vaccines against Covid-19, biopharma hopes to deploy mRNA-based therapies to combat many other diseases in oncology, rare disorders, and beyond.
The 2nd Annual mRNA-Based Therapeutics Summit Europe serves to do precisely this, returning as the only end-to-end industry-dedicated mRNA conference in Europe. Expect the freshest updates on mRNA-based vaccine development & future trajectories, emerging therapeutic approaches based on mRNA, and the route towards accelerated approval to bring about the next wave of mRNA vaccines and therapeutics that broaden the application of this disruptive technology.
Join 250+ Heads, VPs, and Senior Directors in mRNA, RNA, & Vaccines and Nucleic Acid experts from the likes of Sanofi, BioNTech, NEUWAY Pharma, and Pantherna Therapeutics, in Berlin to reach previously untargeted diseases with efficient, non-toxic delivery and clear therapeutic effects with mRNA technology.
What's New for the 2023 Europe Summit?
250+ Attendees from Large Pharma, Biotech & Academia
50+ Thought Leading Speakers
7 Hours of In-Person Networking
3 Pre-Conference Workshops on Formulation, Manufacturing Modulation of mRNA Decay
2 Dedicated Tracks on Discovery and Development & Manufacturing
Focus Day on Next
Generation Nucleic Acid